Press Releases

TARRYTOWN, N.Y., Nov. 5, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today provided an update on the ongoing Phase 3 development program evaluating Libtayo® (cemiplimab), a PD-1 inhibitor, as monotherapy and combination therapy in first-line patients with advanced non-small cell lung cancer (NSCLC). Regeneron is currently rec

MINNEAPOLIS, Nov. 5, 2019 /PRNewswire/ -- DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual

SAN DIEGO, Nov. 5, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced management's participation in the following industry and investor conferences in November:

TARRYTOWN, N.Y., Nov. 5, 2019 /PRNewswire/ --Third quarter 2019 revenues increased 23% to $2.05 billion versus third quarter 2018 Third quarter EYLEA® U.S. net sales increased 16% to $1.19 billion versus third quarter 2018 Du

MARLBOROUGH, Mass., Nov. 5, 2019 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced that, pursuant to the previously announced cash tender offer (the "Tender Offer") for up to $1.0 billion aggregate principal amount (the "Aggregate Maximum Principal Amount") of the outstanding senior notes listed in

GREENWICH, Conn. and INDIANAPOLIS, Nov. 5, 2019 /PRNewswire/ -- Cedar Gate Technologies (Cedar Gate), a leading value-based care analytics company, and Franciscan Alliance, a faith-based, integrated healthcare provider, today announced that their collaboration has resulted in Franciscan Alliance improving the performance of its Franciscan

STAINES-UPON-THAMES, United Kingdom, Nov. 5, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE:  MNK) today announced the commencement of private offers (each, an "Exchange Offer" and, collectively, the "Exchange Offers") by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC (the "Issuers") to exchange:

RADNOR, Pa., Nov. 5, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the quarter ended September 30, 2019."We are pleas

FRANKLIN LAKES, N.J., Nov. 5, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.584 billion for the fourth fiscal quarter ended September 30, 2019.  This represents an increase of 4.1 percent over the prior-year period.  On a comparable, currency-ne

TORONTO, Nov. 5, 2019 /PRNewswire/ - A randomized controlled trial has found that use of Baylis Medical's NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle.The study, entitled Randomized Trial of Conventional